How can we explain the sudden 25% drop in physician adoption rates for Penumbra's RED 62 Reperfusion Catheter in the Midwest region?

Introduction

The sudden 25% drop in physician adoption rates for Penumbra's RED 62 Reperfusion Catheter in the Midwest region is a critical issue that demands immediate attention. This analysis will systematically identify, validate, and address the root cause while considering both short-term and long-term implications for the product and company.

To tackle this problem, I'll employ a structured approach that covers issue identification, hypothesis generation, validation, and solution development. This methodology ensures a comprehensive examination of all potential factors contributing to the adoption rate decline.

Step 1

Clarifying Questions (3 minutes)

• Looking at the regional specificity, I'm wondering about local market dynamics. Has there been any significant change in hospital purchasing policies or insurance coverage in the Midwest region recently?

Why it matters: Regional factors could explain the localized drop in adoption. Expected answer: No major policy changes, but some hospitals have implemented new approval processes. Impact on approach: If confirmed, we'd need to investigate these new processes and their impact on adoption.

• Considering the product lifecycle, I'm curious about the timing. How long has the RED 62 Reperfusion Catheter been on the market, and when did we first notice this adoption rate drop?

Why it matters: Understanding the product's market tenure and the onset of the issue helps identify potential catalysts. Expected answer: The product has been on the market for 2 years, and the drop was first noticed 3 months ago. Impact on approach: This would focus our investigation on recent changes or events within the last 3-6 months.

• Thinking about user segments, I'm interested in the physician profile. Has there been any shift in the demographics or specialties of physicians using the catheter in the Midwest?

Why it matters: Changes in user demographics could indicate underlying issues with product fit or marketing. Expected answer: No significant demographic shifts, but there's been an increase in newer, less experienced physicians in some hospitals. Impact on approach: We'd need to examine our training and onboarding processes for new users.

• Considering potential system issues, I want to confirm our data integrity. Have there been any changes to how we measure or report adoption rates in the past 6 months?

Why it matters: Ensures we're addressing a real issue and not a data anomaly. Expected answer: No changes to measurement or reporting systems. Impact on approach: This would validate that we're dealing with a genuine adoption problem rather than a data issue.